Olive Watson is a seasoned professional in pharmaceutical research and development quality, with extensive experience in regulatory compliance and clinical auditing. Currently serving as Director of R&D Quality at Gilead Sciences since September 2019, Olive has previously held roles as Associate Director of R&D Regulatory Compliance in the same organization, and Principal GCP Auditor at Karyopharm Therapeutics Inc. Olive's experience at Bristol-Myers Squibb spanned several positions from Sr. Compliance Auditor to Sr. Clinical Site Manager, where expertise was honed in GCP audits, regulatory agency interactions, and clinical trial management. Educational qualifications include a Doctor of Nursing Practice focused on Public Health Education and Promotion from the University of Massachusetts - Amherst, along with degrees in Nursing and Public Health from Southern Connecticut State University.
This person is not in any teams
This person is not in any offices